Back to Search
ANDREA STAACK, M.D.
M.D.
Urology Physician
NPI: 1578705208IndividualAccepts Medicare
Specialties, Licenses & Credentials
Urology PhysicianPrimary
Urology
Code: 208800000X
F5519(CA)
CMS Specialties
PrimaryUROLOGY
Education
OTHER
Class of 1999
Research & Publications (20)
Molecular, cellular and developmental biology of urothelium as a basis of bladder regeneration.
PMID 15901280·Differentiation·2005
6-review
Quantitation of apoptotic activity following castration in human prostatic tissue in vivo.
PMID 12518326·Prostate·2003
7-preclinical
Organ and species specificity in the stimulation of transitional epithelial cell growth by fibroblasts.
PMID 11306889·Eur Urol·2001
7-preclinical
Divergent effects of taurolidine as potential anti-neoplastic agent: inhibition of bladder carcinoma cells in vitro and promotion of bladder tumor in vivo.
PMID 19578784·Oncol Rep·2009
7-preclinical
Evaluation of normal prostate tissue, chronic prostatitis, and prostate cancer by quantitative perfusion analysis using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
PMID 18580330·Invest Radiol·2008
8-other
Voxel-based 3D MRI analysis helps to detect subtle forms of subcortical band heterotopia.
PMID 18047585·Epilepsia·2008
5-case
Diagnostic and prognostic validity of serum bone turnover markers in metastatic renal cell carcinoma.
PMID 16952623·J Urol·2006
8-other
[Histopathologic quality of prostate core biopsy specimens: comparison of an MR-compatible biopsy needle and a ferromagnetic biopsy needle used for ultrasound-guided prostate biopsy].
PMID 16933199·Rofo·2006
4-observational
Clinical value of vesical leukoplakia and evaluation of the neoplastic risk by mutation analyses of the tumor suppressor gene TP53.
PMID 16903935·Int J Urol·2006
8-other
Combined determination of plasma MMP2, MMP9, and TIMP1 improves the non-invasive detection of transitional cell carcinoma of the bladder.
PMID 16901349·BMC Urol·2006
4-observational
In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma.
PMID 16596214·Oncol Rep·2006
4-observational
Matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine: tumor-reducing effects on hormone-sensitive prostate cancer in rats.
PMID 16096433·Anticancer Drugs·2005
7-preclinical
Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma.
PMID 16077991·Oncol Rep·2005
4-observational
Phase II trial of weekly paclitaxel and carboplatin chemotherapy in patients with advanced transitional cell cancer.
PMID 15963636·Eur Urol·2005
3-trial
In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder.
PMID 15375521·Oncol Rep·2004
4-observational
Expression of cathepsins B, H, and L and their inhibitors as markers of transitional cell carcinoma of the bladder.
PMID 15183956·Urology·2004
4-observational
Cathepsins B, H, and L activities in urine of patients with transitional cell carcinoma of the bladder.
PMID 11834417·Urology·2002
8-other
Evaluation of three risk scores to predict postoperative nausea and vomiting.
PMID 10757586·Acta Anaesthesiol Scand·2000
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 MEDICAL PLZ, SUITE 140
LOS ANGELES, CA 90095 - Phone
- (310) 794-7700
Quick Facts
- NPI
- 1578705208
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile